| Drug Name: | Ranibizumab (347396-82-1) |
|---|---|
| PubChem ID: | 124033426 |
| SMILES: | CN1CCOC(C1)COC2=C(C=C3C(=C2)C(=NC=[N+]3C4=CC=CC(=C4)CC5=CN=C(N=C5)N6CCN(CC6)C7=NC=NC8=CC(=C(C=C87)OC9CCN(CC9)CCO)OC)N1CCN(CC1)C1=NC=C(C(=O)N1)CC1=CC=CC=C1)OC |
| InchiKey: | IGFXNFIUGHHZEL-UHFFFAOYSA-O |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 1112.33 |
| LogP | : | 4.7249 |
| Ring Count | : | 8 |
| Hydrogen Bond Acceptor Count | : | 19 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 199.9 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category